Bazemore Todd 4
4 · KALA BIO, Inc. · Filed Oct 24, 2025
Insider Transaction Report
Form 4
KALA BIO, Inc.KALA
Bazemore Todd
SEE REMARKS
Transactions
- Sale
Common Stock
2025-10-22$0.83/sh−47,768$39,647→ 35,932 total
Holdings
- 1(indirect: By son)
Common Stock
Footnotes (2)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.82 to $0.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F2]Includes 35,732 unvested RSUs.